Zika Virus real time PCR detection kit
The growing concern about the proliferation of Zika infections in the Caribbean, Central and South America, has turned the fight against the virus in a global health emergency. The infection is mainly transmitted through the bite of the Aedes spp mosquitoes and presents symptoms like mild fever, arthralgia, myalgia, asthenia, headache and maculopapular rash clinical symptoms, plus additional symptoms like conjunctivitis, retroorbital pain, lymphadenopathy and diarrhea. There is widespread concern about the association of the Zika Virus with increasing cases of congenital microcephaly. Other research indicate that the virus can cause brain damage. CerTest Biotec has developed a new kit for the identification of Zika virus in patients presenting symptoms of the disease. This new "ready-for-use" product contains all the necessary components and reagents to perform a test that detects viral Zika RNA using the real time PCR technique. It is very important to complete the identification of the virus in the early stages of infection; therefore, it is recommended that samples of blood, serum and/or saliva are collected during the first 5 days after the onset of symptoms. The VIASURE Zika Virus real time PCR detection kit is designed for specific identification and quantification of Zika virus in clinical samples from patients with signs and symptoms of Zika virus infection. This test is intended for use as an aid in the diagnosis of the Zika virus in humans in combination with clinical and epidemiological risk factors. RNA is extracted from specimens, amplified using RT-amplification and detected using fluorescent reporter dye probes specific for Zika virus.
Supplier: CERTEST BIOTEC
Website:
